endocrinologist glp 1 GLP-1 medications have transformed the conversation around weight loss, but they're not the right choice for everyone., Stanford Medicine Sun Kim, MD, MS, and bariatric and minimally Not a shortcut GLP 1

Appetite level on a 1 to 10 scale each day

Hyperglycemic crises and related neurological sequelae including seizures and altered consciousness may link to suboptimal glycemic control during GLP-1 RA therapy

A 52semanas se observa reduccin del volumen circulante y de la presin arterial, en relacin con la reduccin de adipoquinas y aldosterona, acompaado de disminucin de albuminuria y aumento de filtrado glomerular respecto a placebo, sugiriendo beneficio renal aadido47

Patients 75 years (Wegovy injection and placebo) reported more serious adverse reactions overall compared to younger adult patients Type 2 Diabetes: Wegovy tablets have not been studied for weight reduction in adults with T2D and obesity or overweight

GLP-1 can concurrently stimulate local inhibitory GABA neurons, which indirectly suppress neurons via agouti-related peptide/neuropeptide Y (AgRP + /NPY + ) signalling, thereby reducing feelings of hunger